LB Pharmaceuticals logo
LB Pharmaceuticals
LBRX | NASDAQ
Chart Builder DCF Calculator
$42.99
-$0.02 (-0.05%)
At close: Nov 16, 2026, 4:00 PM ET
$42.99
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

LB Pharmaceuticals Company Profile

Company profile explained

Company Profile

This biopharmaceutical firm is currently in the clinical development stage, concentrating on the creation of innovative treatments for neuropsychiatric disorders such as schizophrenia and bipolar depression. Central to their pipeline is LB-102, their primary investigational drug, which is a methylated variant of amisulpride.

Key Executives

Name Position
Heather D. Turner Chief Executive Officer & Director
Joseph Miller Chief Financial Officer
Anna Eramo Advisor
Christopher Zergebel Senior Vice President of Clinical Operations
Ellen Rose Senior Vice President of Corporate Affairs
James Rawls Senior Vice President of Regulatory Affairs
Kaya Pai Panandiker Chief Commercial Officer
Lindsay Beaupre Senior VP of People & Culture
Marc L. Panoff Senior Vice President of Finance
Minako Pazdera General Counsel
Richard Silva Senior Vice President of Technical Operations
Soffer Chief Operating & Business Officer
Susan G. Kozauer Chief Medical Officer

Latest SEC Filings

Date Type Title
Oct 13, 2026 4 Filing
Oct 13, 2026 4 Filing
Oct 13, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Oct 05, 2026 EFFECT Filing
Oct 01, 2026 POS AM Filing
Oct 01, 2026 S-3ASR Automatic shelf registration statement of securiti...
Sep 24, 2026 3 Filing
Sep 15, 2026 424B3 Filing
Sep 15, 2026 8-K Current Report
Sep 14, 2026 3 Filing
View All SEC Filings ➞
LB Pharmaceuticals
LB Pharmaceuticals logo
Country United States
IPO Date Sep 11, 2025
Industry Biotechnology
Sector Healthcare
Employees 49
CEO Heather D. Turner

Contact Details

One Pennsylvania Plaza New York, New York 10119 United States

Stock Details

Ticker Symbol LBRX
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001691082
CUSIP Number 50180M108
ISIN Number US50180M1080
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.